.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Julphar
Argus Health
Johnson and Johnson
AstraZeneca
Medtronic
Dow
Fish and Richardson
Accenture

Generated: June 24, 2017

DrugPatentWatch Database Preview

METI-DERM Drug Profile

« Back to Dashboard

What is the patent landscape for Meti-derm, and when can generic versions of Meti-derm launch?

Meti-derm is a drug marketed by Schering and is included in one NDA.

The generic ingredient in METI-DERM is prednisolone. There are eighty-five drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the prednisolone profile page.

Summary for Tradename: METI-DERM

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list51
Clinical Trials: see list4
Patent Applications: see list6,750
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:METI-DERM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
METI-DERM
prednisolone
CREAM;TOPICAL010209-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Harvard Business School
Argus Health
Cantor Fitzgerald
Moodys
Cipla
US Department of Justice
Novartis
Daiichi Sankyo
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot